120 related articles for article (PubMed ID: 27341601)
41. Rectal cancer: review with emphasis on MR imaging.
Beets-Tan RG; Beets GL
Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
[TBL] [Abstract][Full Text] [Related]
42. Multimodality management of locally advanced rectal cancer.
Moore HG; Guillem JG
Am Surg; 2003 Jul; 69(7):612-9. PubMed ID: 12889627
[TBL] [Abstract][Full Text] [Related]
43. Treatment of stage II-III rectal cancer patients.
Kim MB; Hong TS; Wo JY
Curr Oncol Rep; 2014; 16(1):362. PubMed ID: 24323626
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?
Tie J; Semira C; Gibbs P
Expert Rev Mol Diagn; 2018 Jan; 18(1):1-3. PubMed ID: 28954554
[No Abstract] [Full Text] [Related]
45. Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients.
De Felice F; Crocetti D; Maiuri V; Parisi M; Marampon F; Izzo L; De Toma G; Musio D; Tombolini V
Curr Treat Options Oncol; 2020 Jan; 21(1):1. PubMed ID: 31927649
[TBL] [Abstract][Full Text] [Related]
46. Controversies in Rectal Cancer Treatment and Management.
Sun W; Al-Rajabi R; Perez RO; Abbasi S; Ash R; Habr-Gama A
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32239978
[TBL] [Abstract][Full Text] [Related]
47. Multidisciplinary management in rectal cancer.
Hervás Morón A; García de Paredes ML; Lobo Martínez E
Clin Transl Oncol; 2010 Dec; 12(12):805-18. PubMed ID: 21156411
[TBL] [Abstract][Full Text] [Related]
48. Where are we now with adjuvant therapy for rectal cancer?
Chapuis P; Bokey L
Aust N Z J Surg; 1997 Sep; 67(9):588-90. PubMed ID: 9322691
[No Abstract] [Full Text] [Related]
49. Progress in rectal cancer staging and treatment.
Pramateftakis MG; Kanellos D; Vrakas G; Tsachalis T; Raptis D; Makrantonakis A; Koukouritaki Z; Kanellos I
Tech Coloproctol; 2010 Nov; 14 Suppl 1():S29-31. PubMed ID: 20686807
[TBL] [Abstract][Full Text] [Related]
50. Outcome measures in multimodal rectal cancer trials.
Fokas E; Glynne-Jones R; Appelt A; Beets-Tan R; Beets G; Haustermans K; Marijnen C; Minsky BD; Ludmir E; Quirke P; Sebag-Montefiore D; Garcia-Aguilar J; Gambacorta MA; Valentini V; Buyse M; Rödel C
Lancet Oncol; 2020 May; 21(5):e252-e264. PubMed ID: 32359501
[TBL] [Abstract][Full Text] [Related]
51. [Clinical research for rectal carcinoma: State of the art and objectives].
Maingon P; Simon JM; Canova CH; Troussier I; Besson N; Caillot É; Huguet F
Cancer Radiother; 2017 Oct; 21(6-7):533-535. PubMed ID: 28890092
[TBL] [Abstract][Full Text] [Related]
52. Major 20th-century advancements in the management of rectal cancer.
Ruo L; Guillem JG
Dis Colon Rectum; 1999 May; 42(5):563-78. PubMed ID: 10344677
[No Abstract] [Full Text] [Related]
53. Combined-treatment approaches in the management of rectal cancer.
Gunderson LL
Recent Results Cancer Res; 1988; 110():119-29. PubMed ID: 3043587
[No Abstract] [Full Text] [Related]
54. [Changes in therapy of resectable rectal carcinoma].
Link KH
Internist (Berl); 2001 Jun; 42(6):910-2. PubMed ID: 11449638
[No Abstract] [Full Text] [Related]
55. [Treatment for locally recurrent rectal cancer].
Kanemitsu Y; Shida D; Tsukamoto S; Ochiai H; Komori K; Moriya Y
Nihon Shokakibyo Gakkai Zasshi; 2014 Nov; 111(11):2113-20. PubMed ID: 25373372
[No Abstract] [Full Text] [Related]
56. Survival after postoperative combination treatment of rectal cancer.
Douglass HO; Moertel CG; Mayer RJ; Thomas PR; Lindblad AS; Mittleman A; Stablein DM; Bruckner HW;
N Engl J Med; 1986 Nov; 315(20):1294-5. PubMed ID: 3773947
[No Abstract] [Full Text] [Related]
57. Controversies in rectal cancer.
Hershman MJ
Br J Hosp Med (Lond); 2013 Jul; 74(7):366. PubMed ID: 24159635
[No Abstract] [Full Text] [Related]
58. IORT as adjuvant treatment in primary rectal carcinomas: multi-modality treatment.
Eble MJ; Lehnert T; Herfarth C; Wannenmacher M
Front Radiat Ther Oncol; 1997; 31():200-3. PubMed ID: 9263822
[No Abstract] [Full Text] [Related]
59. Local Option: The Rational Use of Local Therapy in Patients at High Risk to Die of Metastatic Progression.
Boffa DJ
J Oncol Pract; 2018 Jun; 14(6):344-349. PubMed ID: 29894660
[TBL] [Abstract][Full Text] [Related]
60. [Who can be dismissed in rectal cancer management?].
Rouanet P
Cancer Radiother; 2017 Oct; 21(6-7):536-538. PubMed ID: 28864048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
